How dendritic cells shape atherosclerosis

Trends in Immunology

Volumn 32, Issue 11, 2011, Pages 540-547

  Koltsova, Ekaterina K ^a   Ley, Klaus ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ARTERY WALL; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; LIPID STORAGE; NONHUMAN; REVIEW; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; HUMANS; LIPID METABOLISM;

EID: 82455219098     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.07.001     Document Type: Review

References (86)

1. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis*. Annu. Rev. Immunol. 2009, 27:165-197.
2. Andersson J., et al. Adaptive immunity and atherosclerosis. Clin. Immunol. 2010, 134:33-46.
3. Steinman R.M., et al. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J. Exp. Med. 1975, 141:804-820.
4. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006, 311:17-58.
5. Banchereau J., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
6. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clin. Immunol. 2010, 134:25-32.
7. Bobryshev Y.V. Dendritic cells and their role in atherogenesis. Lab. Invest. 2010, 90:970-984.
8. Geissmann F., et al. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
9. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829-5835.
10. Wu H., et al. Functional role of CD11c+monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009, 119:2708-2717.
11. Gower R.M., et al. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler. Thromb. Vasc. Biol. 2011, 31:160-166.
12. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 2010, 7:77-86.
13. Ley K., et al. Monocyte and macrophage dynamics during atherogenesis. Atheroscler. Thromb. Vasc. Biol. 2011, 31:1506-1516.
14. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
15. Serbina N.V., et al. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
16. Reizis B. Regulation of plasmacytoid dendritic cell development. Curr. Opin. Immunol. 2010, 22:206-211.
17. Johansson-Lindbom B., et al. Functional specialization of gut CD103+dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 2005, 202:1063-1073.
18. Coombes J.L., et al. A functionally specialized population of mucosal CD103+DCs induces Foxp3+regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
19. Sun C.M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
20. Bedoui S., et al. Cross-presentation of viral and self antigens by skin-derived CD103+dendritic cells. Nat. Immunol. 2009, 10:488-495.
21. Hall J.A., et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity 2011, 34:435-447.
22. DePaolo R.W., et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011, 471:220-224.
23. Mempel T.R., et al. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004, 427:154-159.
24. Qu C., et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 2004, 200:1231-1241.
25. Joffre O., et al. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009, 227:234-247.
26. Salio M., et al. Recent advances in processing and presentation of CD1 bound lipid antigens. Curr. Opin. Immunol. 2010, 22:81-88.
27. Yamazaki S., Steinman R.M. Dendritic cells as controllers of antigen-specific Foxp3+regulatory T cells. J. Dermatol. Sci. 2009, 54:69-75.
28. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
29. Chen G., et al. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 2009, 4:365-398.
30. Blander J.M., Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006, 440:808-812.
31. McDonald O.G., Owens G.K. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 2007, 100:1428-1441.
32. Bobryshev Y.V., Lord R.S. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc. Res. 1995, 29:689-696.
33. Stoneman V., et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 2007, 100:884-893.
34. Mantovani A., et al. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1419-1423.
35. Soehnlein O., Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin. Immunopathol. 2009, 31:35-47.
36. Moos M.P., et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2386-2391.
37. Choi J.H., et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 2009, 206:497-505.
38. Paulson K.E., et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 2010, 106:383-390.
39. Jongstra-Bilen J., et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 2006, 203:2073-2083.
40. Cybulsky M.I., Jongstra-Bilen J. Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 2010, 21:397-403.
41. Auffray C., et al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 2009, 206:595-606.
42. Liu K., et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
43. Fogg D.K., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
44. Zernecke A., et al. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1897-1908.
45. Combadiere C., et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003, 107:1009-1016.
46. Combadiere C., et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008, 117:1649-1657.
47. Liu P., et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 2008, 28:243-250.
48. Trogan E., et al. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3781-3786.
49. Langer H.F., et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1463-1470.
50. Zhu S.N., et al. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 2009, 206:2141-2149.
51. Kabashima K., et al. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
52. Packard R.R., et al. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ. Res. 2008, 103:965-973.
53. Llodra J., et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11779-11784.
54. Landsman L., et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009, 113:963-972.
55. Gautier E.L., et al. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009, 119:2367-2375.
56. Buono C., et al. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2004, 109:2009-2015.
57. Sun J., et al. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 2010, 122:808-820.
58. Galkina E., et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 2006, 203:1273-1282.
59. Kunjathoor V.V., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002, 277:49982-49988.
60. Stewart C.R., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
61. Miller Y.I., et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 2011, 108:235-248.
62. Faure-Andre G., et al. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 2008, 322:1705-1710.
63. Boulesteix T., et al. Micrometer scale ex vivo multiphoton imaging of unstained arterial wall structure. Cytometry A 2006, 69:20-26.
64. Erbel C., et al. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res. Cardiol. 2007, 102:123-132.
65. Hermansson A., et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 2010, 207:1081-1093.
66. Branen L., et al. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2137-2142.
67. Schieffer B., et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004, 110:3493-3500.
68. Huber S.A., et al. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2364-2367.
69. Davenport P., Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 2003, 163:1117-1125.
70. Lee T.S., et al. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19:734-742.
71. Hauer A.D., et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005, 112:1054-1062.
72. Zhang X., et al. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ. Res. 2006, 98:524-531.
73. Kastelein R.A., et al. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 2007, 25:221-242.
74. Goossens P., et al. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab. 2010, 12:142-153.
75. Greaves D.R., et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2001, 21:923-929.
76. Huang D.R., et al. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 2001, 193:713-726.
77. Bystry R.S., et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2001, 2:1126-1132.
78. Braunersreuther V., et al. The specific role of chemokines in atherosclerosis. Thromb. Haemost. 2007, 97:714-721.
79. Grabner R., et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J. Exp. Med. 2009, 206:233-248.
80. Mebius R.E., et al. Developing lymph nodes collect CD4+CD3- LTbeta+cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7:493-504.
81. Cupedo T., et al. The role of CD45+CD4+CD3- cells in lymphoid organ development. Immunol. Rev. 2002, 189:41-50.
82. Lotzer K., et al. Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler. Thromb. Vasc. Biol. 2010, 30:395-402.
83. Marinkovic T., et al. Interaction of mature CD3+CD4+T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Invest. 2006, 116:2622-2632.
84. Palinski W., et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 1996, 98:800-814.
85. Schett G., et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 1995, 96:2569-2577.
86. Xu Q., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102:14-20.